PuSH - Publication Server of Helmholtz Zentrum München

The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.

Oncol. Res. Treat. 38, 214 (2015)
Open Access Green as soon as Postprint is submitted to ZB.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Meeting abstract
Reviewing status